|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pang C, Guan Y, Li H, Chen W and Zhu G:
Urologic cancer in China. Jpn J Clin Oncol. 46:497–501. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhu Y, Yang XQ, Han CT, Dai B, Zhang HL,
Shi GH, Wang CF and Ye DW: Pathological features of localized
prostate cancer in China: A contemporary analysis of radical
prostatectomy specimens. PLoS One. 10:e01210762015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Acosta AM, Al Rasheed MRH, Rauscher GH,
Vormittag E, Mon KS, Sharif A, Kajdacsy-Balla A and Mohapatra G:
Tumor necrosis in radical prostatectomies with high-grade prostate
cancer is associated with multiple poor prognostic features and a
high prevalence of residual disease. Hum Pathol. 75:1–9. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang C, Tao W, Ni S, Chen Q, Zhao Z, Ma L,
Fu Y and Jiao Z: Tumor-suppressive microRNA-145 induces growth
arrest by targeting SENP1 in human prostate cancer cells. Cancer
Sci. 106:375–382. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ding C, Tian Q, Li J, Jiao M, Song S, Wang
Y, Miao Z and Zhang A: Structural modification of natural product
Tanshinone I leading to discovery of novel nitrogen-enriched
derivatives with enhanced anticancer profile and improved drug-like
properties. J Med Chem. 61:760–776. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Han C, Li Z, Hou J, Wang Z, Xu D, Xue G
and Kong L: Bioactivity evaluation of natural product α-mangostin
as a novel xanthone-based lysine-specific demethylase 1 inhibitor
to against tumor metastasis. Bioorg Chem. 76:415–419. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang L, Huo X, Liao Y, Yang F, Gao L and
Cao L: Zeylenone, a naturally occurring cyclohexene oxide, inhibits
proliferation and induces apoptosis in cervical carcinoma cells via
PI3K/AKT/mTOR and MAPK/ERK pathways. Sci Rep. 7:16692017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang L, Jin J, Zhang L, Hu R, Gao L, Huo
X, Liu D, Ma X, Wang C, Han J, et al: Quantitative analysis of
differential protein expression in cervical carcinoma cells after
zeylenone treatment by stable isotope labeling with amino acids in
cell culture. J Proteomics. 126:279–287. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hu X, Han R, Quan LH, Liu CY and Liao YH:
Stabilization and sustained release of zeylenone, a soft cytotoxic
drug, within polymeric micelles for local antitumor drug delivery.
Int J Pharm. 450:331–337. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang LL, Li RY, Zhang LJ, Chen D, Huo XW,
Li LY and Cao L: Inhibitory effect of Zeylenone on proliferation
and apoptosis of human PC-3 cells. Chine Pharmacol Bull.
29:809–813. 2013.
|
|
12
|
Airola K, Karonen T, Vaalamo M, Lehti K,
Lohi J, Kariniemi AL, Keski-Oja J and Saarialho-Kere UK: Expression
of collagenases-1 and −3 and their inhibitors TIMP-1 and −3
correlates with the level of invasion in malignant melanomas. Br J
Cancer. 80:733–743. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Barriere G, Tartary M and Rigaud M:
Metformin: A rising star to fight the epithelial mesenchymal
transition in oncology. Anticancer Agents Med Chem. 13:333–340.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Elkin M, Ariel I, Miao HQ, Nagler A, Pines
M, de-Groot N, Hochberg A and Vlodavsky I: Inhibition of bladder
carcinoma angiogenesis, stromal support, and tumor growth by
halofuginone. Cancer Res. 59:4111–4118. 1999.PubMed/NCBI
|
|
15
|
Kahlert UD, Nikkhah G and Maciaczyk J:
Epithelial-to-mesenchymal(-like) transition as a relevant molecular
event in malignant gliomas. Cancer Lett. 331:131–138. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gillers BS, Chiplunkar A, Aly H, Valenta
T, Basler K, Christoffels VM, Efimov IR, Boukens BJ and Rentschler
S: Canonical wnt signaling regulates atrioventricular junction
programming and electrophysiological properties. Cir Res.
116:398–406. 2015. View Article : Google Scholar
|
|
17
|
Monga SP: β-catenin signaling and roles in
liver homeostasis, injury, and tumorigenesis. Gastroenterology.
148:1294–1310. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li J, Yang S, Su N, Wang Y, Yu J, Qiu H
and He X: Overexpression of long non-coding RNA HOTAIR leads to
chemoresistance by activating the Wnt/β-catenin pathway in human
ovarian cancer. Tumour Biol. 37:2057–2065. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Peng Y, Zhang X, Ma Q, Yan R, Qin Y, Zhao
Y, Cheng Y, Yang M, Wang Q, Feng X, et al: MiRNA-194 activates the
Wnt/β-catenin signaling pathway in gastric cancer by targeting the
negative Wnt regulator, SUFU. Cancer Lett. 385:117–127. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Vilchez V, Turcios L, Marti F and Gedaly
R: Targeting Wnt/β-catenin pathway in hepatocellular carcinoma
treatment. World J Gastroenterol. 22:823–832. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Method. 25:402–408. 2001.
View Article : Google Scholar
|
|
22
|
Huang K, Tang Y, He L and Dai Y:
MicroRNA-340 inhibits prostate cancer cell proliferation and
metastasis by targeting the MDM2-p53 pathway. Oncol Rep.
35:887–895. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li Y, Luo H, Xiao N, Duan J, Wang Z and
Wang S: Long noncoding RNA SChLAP1 accelerates the proliferation
and metastasis of prostate cancer via targeting miR-198 and
promoting the MAPK1 pathway. Oncol Res. 26:131–143. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wei XL, Han R, Hu X, Quan LH, Liu CY,
Chang Q and Liao YH: Stabilization of zeylenone in rat plasma by
the presence of esterase inhibitors and its LC-MS/MS assay for
pharmacokinetic study. Biomed Chromatogr. 27:636–640. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang K, Wu F, Seo BR, Fischbach C, Chen W,
Hsu L and Gourdon D: Breast cancer cells alter the dynamics of
stromal fibronectin-collagen interactions. Matrix Biol.
60–61:86–95. 2017. View Article : Google Scholar
|
|
26
|
Zhou XM, Hou G, Gu DX, Wang QY and Zhao L:
Peroxisome proliferator-activated receptor-γ in induced sputum is
correlated with MMP-9/TIMP-1 imbalance and formation of emphysema
in COPD patients. J Thorac Dis. 9:3703–3710. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hatmaker AR, Gi YJ, Schmidt CR, Beauchamp
RD, Coffey RJ and Pearson AS: Targeted loss of E-cadherin is
sufficient to induce dedifferentiation, loss of intercellular
junctions, and increased invasive potential of colorectal cancer
cells. Cancer Res. 66:5882006.PubMed/NCBI
|
|
28
|
Vu T and Datta PK: Regulation of EMT in
colorectal cancer: A culprit in metastasis. Cancers (Basel). 9:pii:
E171. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chouat E, Zehani A, Chelly I, Njima M,
Maghrebi H, Bani MA, Njim L, Zakhama A, Haouet S and Kchir N: Tumor
budding is a prognostic factor linked to epithelial mesenchymal
transition in pancreatic ductal adenocarcinoma. Study report and
literature review. Pancreatology. 18:79–84. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fatima I, El-Ayachi I, Taotao L, Lillo MA,
Krutilina R, Seagroves TN, Radaszkiewicz TW, Hutnan M, Bryja V,
Krum SA, et al: The natural compound Jatrophone interferes with
Wnt/β-catenin signaling and inhibits proliferation and EMT in human
triple-negative breast cancer. PLoS One. 12:e01898642017.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jiang Y, Ren W, Wang W, Xia J, Gou L, Liu
M, Wan Q, Zhou L, Weng Y, He T and Zhang Y: Inhibitor of β-catenin
and TCF (ICAT) promotes cervical cancer growth and metastasis by
disrupting E-cadherin/β-catenin complex. Oncol Rep. 38:2597–2606.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xie SL, Fan S, Zhang SY, Chen WX, Li QX,
Pan GK, Zhang HQ, Wang WW, Weng B, Zhang Z, et al: SOX8 regulates
cancer stem-like properties and cisplatin-induced EMT in tongue
squamous cell carcinoma by acting on the Wnt/β-catenin pathway. Int
J Cancer. 142:1252–1265. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Clevers H and Nusse R: Wnt/β-catenin
signaling and disease. Cell. 149:1192–1205. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Dissanayake SK, Wade M, Johnson CE,
O'Connell MP, Leotlela PD, French AD, Shah KV, Hewitt KJ, Rosenthal
DT, Indig FE, et al: The Wnt5A/protein kinase C pathway mediates
motility in melanoma cells via the inhibition of metastasis
suppressors and initiation of an epithelial to mesenchymal
transition. J Biol Chem. 282:17259–17271. 2007. View Article : Google Scholar : PubMed/NCBI
|
